Teva Pharmaceutical Chief Legal Officer Plans Sale of 7,028 Ordinary Shares
TEVA PHARMACEUTICAL INDUSTRIES LTD
Subscribe to track TEVA
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Form 144 Notice of Proposed Sale of Securities • Issuer: TEVA PHARMACEUTICAL INDUSTRIES LTD ($TEVA) • Filer: Savage Brian (CHIEF LEGAL OFFICER) • Securities to Sell: 7,028 ORDINARY SHARES • Aggregate Value: $273,062.13 (~$38.85/share) • Approx. Sale Date: 09/18/2026 • Broker: CITIGROUP GLOBAL MARKETS • Acquisition Sources: Rollover shares and cashless option exercise
Comprehensive Analysis
Executive Summary
On September 21, 2026, a Form 144 was filed on behalf of Brian Savage, Chief Legal Officer of Teva Pharmaceutical Industries Ltd (CIK: 0000818686), proposing the sale of 7,028 Ordinary Shares through Citigroup Global Markets. The total estimated market value of the proposed transaction is $273,062.13 (approx. $38.85 per share), with an approximate sale date of September 18, 2026.
Transaction Details
- Securities Class: Ordinary Shares
- Volume: 7,028 shares
- Gross Value: $273,062.13
- Broker: Citigroup Global Markets
- Securities Acquisition Breakdown:
- 550 shares acquired on 03/05/2025 via rollover shares as compensation.
- 1,975 shares acquired on 03/03/2026 via rollover shares as compensation.
- 4,503 shares acquired on 09/18/2026 via cashless option exercise and sale.
Context and Market Significance
This filing represents a relatively routine disposition tied to equity compensation and cashless option exercise. Relative to Teva's massive share base, the 7,028 shares represent a negligible fraction of outstanding units. Therefore, the trading significance of this transaction is rated Low.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.